Action ALPS - ALPS

ALPS Group Inc (ALPS) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

0,72

( 3,15% )

Prix Achat

0,63

Prix Vente

1,02

Volume échangé

20 518

0,66 Fourchette du Jour 0,727

0,1425 Plage de 52 semaines 1,75

Cap du marché

119,808M

Clôture Veille

0,698

Ouverture

0,719

Dernière Transaction

100

0.72

Dernière heure de transaction

Volume financier

US$ 14 081

VWAP

0,686265

Volume moyen (3 m)

US$ 23 216

Actions en circulation

166 400 326

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-15,93

Bénéfice par action (BPA)

-0,05

Chiffre d'affairess (LTM)

3,74M

Bénéfice net (LTM)

-2,64M

Alps Group Inc, a biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies. The company is based in Kuala Lumpur, Malaysia. Alps Group Inc, a biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies. The company is based in Kuala Lumpur, Malaysia.

Secteur

Industrie

Site Web

alps-holdings.com

Siège social

Kuala Lumpur, Malaysia

Fondé

ALPS Group Inc est coté dans le secteur de la NASDAQ avec le ticker ALPS. Le dernier cours de clôture d'ALPS était de US$0,70. Au cours de la dernière année, les actions de ALPS ont été négociées dans une fourchette de prix de US$ 0,1425 à US$ 1,75.

ALPS compte actuellement 166 400 326 actions en circulation. La capitalisation boursière d'ALPS est de US$119,81 million. ALPS a un ratio cours/bénéfice (ratio PE) de -15.93.

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

KUALA LUMPUR, Malaysia, June 09, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (“Alps” or “the Company”) (Nasdaq:...

Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

KUALA LUMPUR, Malaysia, May 19, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the...

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”...

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the...

Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the...

Alps Announces Closing of Business Combination with Globalink Investment Inc.

KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.06	9.09090909091	0.66	0.77	0.64	9556	0.73623257	CS
4	-0.018249	-2.47193020241	0.738249	0.779	0.635	30788	0.71105858	CS
12	-0.29	-28.7128712871	1.01	1.05	0.635	22970	0.80013073	CS
26	-0.2675	-27.0886075949	0.9875	1.39	0.635	36005	0.94350822	CS
52	0.5775	405.263157895	0.1425	1.75	0.1425	102356	1.04981648	CS
156	0.0599	9.07438266929	0.6601	1.75	0.14	61599	0.7388479	CS
260	-4.28	-85.6	5	6.18	0.14	71056	0.89614053	CS

ALPS - Frequently Asked Questions (FAQ)

What is the current ALPS Group Inc share price?

The current share price of ALPS Group Inc is US$ 0,72

How many ALPS Group Inc shares are in issue?

ALPS Group Inc has 166 400 326 shares in issue

What is the market cap of ALPS Group Inc?

The market capitalisation of ALPS Group Inc is USD 119,81M

What is the 1 year trading range for ALPS Group Inc share price?

ALPS Group Inc has traded in the range of US$ 0,1425 to US$ 1,75 during the past year

What is the PE ratio of ALPS Group Inc?

The price to earnings ratio of ALPS Group Inc is -15,93

What is the cash to sales ratio of ALPS Group Inc?

The cash to sales ratio of ALPS Group Inc is 32,24

What is the registered address of ALPS Group Inc?

The registered address for ALPS Group Inc is Icon Tower (East), Kuala Lumpur, Wilayah Persekutuan, 50400

What is the ALPS Group Inc website address?

The website address for ALPS Group Inc is alps-holdings.com

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ALPS Group Inc (ALPS)

ALPS Group Inc (ALPS) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de ALPS Group Inc

ALPS Dernières nouvelles

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

Alps Announces Closing of Business Combination with Globalink Investment Inc.

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

SPAC News From The Last Seven Days

Alps Announces Closing of Business Combination with Globalink Investment Inc.

ALPS - Frequently Asked Questions (FAQ)

ALPS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ALPS Group Inc (ALPS)

ALPS Group Inc (ALPS) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de ALPS Group Inc

ALPS Dernières nouvelles

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

Alps Announces Closing of Business Combination with Globalink Investment Inc.

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

SPAC News From The Last Seven Days

Alps Announces Closing of Business Combination with Globalink Investment Inc.

ALPS - Frequently Asked Questions (FAQ)

ALPS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités